This is a non-core endpoint: only basic statistics are computed.
Other blood glucose lowering drugs, excl. Insulins
GLUCLOW_OTH
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
A10BX
1 out of 7 registries used, show all original rules.
5822
Check minimum number of events
Min. number of events
3
5822
Include endpoints None
5822
Remove individuals based on genotype QC
5642
GLUCLOW_OTH
Control definitions
Control exclude
DIAB_MED_OTHER
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other blood glucose lowering drugs, excl. Insulins
based on the number of shared cases.
Broader endpoints:
- Other (not insulin) diabetes medications
- Diabetes medication
- Type 2 diabetes
- Diabetes mellitus
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5642 | 2816 | 2826 |
| Unadjusted prevalence (%) | 1.37 | 1.22 | 1.55 |
| Mean age at first event (years) | 57.71 | 56.65 | 58.75 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: GLUCLOW_OTH – Other blood glucose lowering drugs, excl. Insulins
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other blood glucose lowering drugs, excl. Insulins
↥Endpoint not on priority list, no data to show.